Phosphorylation of eIF2α is required for mRNA translation inhibition and survival during moderate hypoxia
- 30 June 2007
- journal article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 83 (3), 353-361
- https://doi.org/10.1016/j.radonc.2007.04.031
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapyRadiotherapy and Oncology, 2007
- Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: The need for a multivariate approach in biomarker studiesRadiotherapy and Oncology, 2006
- Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude miceRadiotherapy and Oncology, 2006
- Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancerRadiotherapy and Oncology, 2006
- Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational controlThe EMBO Journal, 2006
- Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center studyRadiotherapy and Oncology, 2005
- The hypoxic proteome is influenced by gene-specific changes in mRNA translationRadiotherapy and Oncology, 2005
- Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCCRadiotherapy and Oncology, 2005
- Modulation of cell death in the tumor microenvironmentSeminars in Radiation Oncology, 2003
- Regulation of Protein Synthesis by Hypoxia via Activation of the Endoplasmic Reticulum Kinase PERK and Phosphorylation of the Translation Initiation Factor eIF2αMolecular and Cellular Biology, 2002